Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07366502

Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy

Conditions: İron Deficiency Anemia, Liposomal Iron Replacement, Conventional Iron Replacement

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 70
Sponsor: Medeni Şermet

Location: Goztepe Prof.Dr. Suleyyman Yalçın City Hospital Istanbul kadıköy

Summary

Low-dose liposomal iron (17-34 mg elemental/day) was compared with standard conventional oral iron (100-200mg elemental/day) in the treatment of iron deficiency anemia following sleeve gastrectomy. Liposomal iron provided superior hematological improvement and gastrointestinal tolerance.

Eligibility Criteria

Inclusion Criteria * Age between 18 and 65 years * History of laparoscopic sleeve gastrectomy performed at least 6 months prior to enrollment * Diagnosis of iron deficiency anemia, defined as: * Hemoglobin \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07366502). StuddyBuddy aggregates publicly available trial information.